Repare Therapeutics is a clinical-stage precision oncology company focused on developing targeted therapies that address genetic alterations in tumors using its proprietary SNIPRx platform for synthetic lethality-based therapeutics
Repare Therapeutics is a clinical-stage precision oncology company focused on developing targeted therapies that address genetic alterations in tumors using its proprietary SNIPRx platform for synthetic lethality-based therapeutics.
The top three firms on F4's Biotech & Life Sciences investor list.